New hypoallergenic formula aims to help babies with milk allergy grow normally
NCT ID NCT07711938
First seen Jul 17, 2026 · Last updated Jul 17, 2026
Summary
This study compares a new extensively hydrolyzed formula (eHF) to a standard eHF in full-term infants diagnosed with cow's milk protein allergy (CMPA). The goal is to see if the new formula supports healthy growth and is as safe and well-tolerated as the standard one. Infants aged 29 days to under 5 months who are not breastfed and have a history of allergic reactions to cow's milk may participate. The trial tracks weight gain over 16 weeks and monitors for any adverse events.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a new extensively hydrolyzed whey-based formula for infants with cow's milk protein allergy
- What this could lead to
- If successful, this new formula could offer a safe and effective option for managing cow's milk protein allergy in infants, supporting normal growth.
- What could go wrong
- This is a non-inferiority trial, so the new formula may not prove better than the existing one. Results are specific to full-term infants and may not apply to all cases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COW MILK PROTEIN ALLERGY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.